FI934411A7 - Kinolonikarboksyylihappoja - Google Patents

Kinolonikarboksyylihappoja Download PDF

Info

Publication number
FI934411A7
FI934411A7 FI934411A FI934411A FI934411A7 FI 934411 A7 FI934411 A7 FI 934411A7 FI 934411 A FI934411 A FI 934411A FI 934411 A FI934411 A FI 934411A FI 934411 A7 FI934411 A7 FI 934411A7
Authority
FI
Finland
Prior art keywords
carboxylic acids
quinolone carboxylic
quinolone
acids
carboxylic
Prior art date
Application number
FI934411A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934411L (fi
FI934411A0 (fi
Inventor
Karl Georg Metzger
Rainer Endermann
Uwe Petersen
Andreas Krebs
Thomas Schenke
Klaus Grohe
Wilfried Schröck
Dieter Häbisch
Klaus-Dieter Bremm
Thomas Philipps
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI934411A0 publication Critical patent/FI934411A0/fi
Publication of FI934411L publication Critical patent/FI934411L/fi
Publication of FI934411A7 publication Critical patent/FI934411A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI934411A 1992-10-09 1993-10-07 Kinolonikarboksyylihappoja FI934411A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4234078A DE4234078A1 (de) 1992-10-09 1992-10-09 Chinoloncarbonsäuren

Publications (3)

Publication Number Publication Date
FI934411A0 FI934411A0 (fi) 1993-10-07
FI934411L FI934411L (fi) 1994-04-10
FI934411A7 true FI934411A7 (fi) 1994-04-10

Family

ID=6470084

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934411A FI934411A7 (fi) 1992-10-09 1993-10-07 Kinolonikarboksyylihappoja

Country Status (19)

Country Link
US (1) US5480879A (esLanguage)
EP (1) EP0591808A1 (esLanguage)
JP (1) JPH0820587A (esLanguage)
KR (1) KR940009193A (esLanguage)
CN (1) CN1090285A (esLanguage)
AU (1) AU666772B2 (esLanguage)
CA (1) CA2107812A1 (esLanguage)
CZ (1) CZ9302001A3 (esLanguage)
DE (1) DE4234078A1 (esLanguage)
FI (1) FI934411A7 (esLanguage)
HU (1) HUT66376A (esLanguage)
IL (1) IL107188A0 (esLanguage)
MX (1) MX9306023A (esLanguage)
NO (1) NO933393L (esLanguage)
NZ (1) NZ248871A (esLanguage)
PL (1) PL300628A1 (esLanguage)
SK (1) SK109293A3 (esLanguage)
TW (1) TW288018B (esLanguage)
ZA (1) ZA937474B (esLanguage)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7706394A (en) * 1994-02-25 1995-09-11 Arrieta Munguia, Judith Marcia Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them
AU718806B2 (en) * 1995-02-17 2000-04-20 Daiichi Asubio Pharma Co., Ltd. Penem derivatives and antimicrobial agent containing the same
DE19546249A1 (de) 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
RU2193558C2 (ru) * 1997-09-15 2002-11-27 Дзе Проктер Энд Гэмбл Компани Производные хинолона и фармацевтическая композиция на их основе
DE19751948A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
DE19821039A1 (de) 1998-05-11 1999-11-18 Bayer Ag Verfahren zur Herstellung von (S,S)-Benzyl-2,8-diazabicyclo[4.3.0]nonan
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) * 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
DE19927412A1 (de) * 1999-06-16 2000-12-21 Bayer Ag Verfahren zur Enantiomerenanreicherung von cis-8-Benzyl-7,9-dioxo-2,8-diazabicyclo [4.3.0]nonan
DE19931115A1 (de) * 1999-07-06 2001-01-11 Bayer Ag Racemisierung von R, S-Dioxo-Benzylpyrrolopiperidin
AU2001261748A1 (en) * 2000-05-19 2001-12-03 Alcon Laboratories Inc. Antibiotic compositions for treatment of the eye, ear and nose
EP2495245A3 (en) * 2004-06-10 2012-12-19 FOB Synthesis, Inc. Gram-positive carbapenem antibacterials and processes for their preparation
CN1325494C (zh) * 2005-08-18 2007-07-11 中国药科大学 3-位取代的萘啶酮类化合物及其制备方法和在制药中的应用
WO2007110835A2 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
MY148393A (en) 2006-03-28 2013-04-15 Taigen Biotechnology Co Ltd Malate salts, and polymorphs of (3s, 5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
US7692015B2 (en) * 2007-01-05 2010-04-06 Zheqing Wang Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
FR2928150A1 (fr) * 2008-02-29 2009-09-04 Vetoquinol Sa Sa Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
IT1393337B1 (it) 2009-03-06 2012-04-20 Italiana Sint Spa Sintesi di (4as, 7as)-ottaidro-1h-pirrolo[3,4-b]piridina
MX2011012134A (es) 2009-05-15 2012-02-08 Redx Pharma Ltd Derivados de farmaco de oxido-reduccion.
CA2802529C (en) 2010-06-18 2019-10-29 Woo-Baeg Choi Carbapenem antibacterials with gram-negative activity
CN102952130B (zh) * 2011-08-24 2016-03-23 重庆华邦胜凯制药有限公司 手性合成(s,s)-2,8-二氮杂双环壬烷的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT49889A (en) * 1988-03-31 1989-11-28 Hoffmann La Roche Process for producing acyl derivatives
CS273349B2 (en) * 1988-03-31 1991-03-12 Hoffmann La Roche Method of cephalosporin's new derivatives production
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
JPH03188080A (ja) * 1989-12-15 1991-08-16 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
ZA912279B (en) * 1990-04-09 1992-02-26 Hoffmann La Roche Carbapenem compounds
EP0492277A3 (en) * 1990-12-20 1992-10-14 F. Hoffmann-La Roche Ag Cephalosporin derivatives

Also Published As

Publication number Publication date
NO933393L (no) 1994-04-11
NZ248871A (en) 1995-12-21
KR940009193A (ko) 1994-05-20
MX9306023A (es) 1994-05-31
FI934411L (fi) 1994-04-10
IL107188A0 (en) 1994-01-25
PL300628A1 (en) 1994-05-16
NO933393D0 (no) 1993-09-23
US5480879A (en) 1996-01-02
ZA937474B (en) 1994-04-26
AU666772B2 (en) 1996-02-22
DE4234078A1 (de) 1994-04-14
SK109293A3 (en) 1994-09-07
TW288018B (esLanguage) 1996-10-11
HUT66376A (en) 1994-11-28
FI934411A0 (fi) 1993-10-07
CN1090285A (zh) 1994-08-03
CZ9302001A3 (en) 1994-04-13
CA2107812A1 (en) 1994-04-10
EP0591808A1 (de) 1994-04-13
HU9302843D0 (en) 1993-12-28
JPH0820587A (ja) 1996-01-23
AU4864493A (en) 1994-04-21

Similar Documents

Publication Publication Date Title
FI934411A7 (fi) Kinolonikarboksyylihappoja
NO924978D0 (no) Chinolon- og naftyridon-karboksylsyrederivater
FI940642L (fi) Imidatsolyyli-alkeenihapot
NO922226D0 (no) 7-isoindolinyl-kinolon- og naftyridonkarboksylsyre-derivater
FI943948A7 (fi) Heterosykliset hiilihappojohdannaiset
FI921135A7 (fi) Uusia karbonihappoamideja
PT100087A (pt) Novos esteres de esteroides
NO940039D0 (no) Chinolon- og naftyridonkarboksylsyrederivater
FI930063L (fi) Polyeterfosfatestrar
FI922095L (fi) Substituerade karboxylsyraderivat
FI924570A7 (fi) Bentsimidatsolifosfonoaminohappoja
DE69133019D1 (de) Imidazolyl-alkencarbonsäuren
NO923508D0 (no) Bicykliske karboksylsyrederivater
DE59305938D1 (de) Pyridyloxy-acrylsäureester
FI920033A7 (fi) Menetelmä karboksyylihappojen puhdistamiseksi
HU9600322D0 (en) Novel quinolone carboxylic acid derivatives
DK637888A (da) Carboxylsyreestere
FI951341L (fi) Bentseenialkanoiinihapot sydän-verisuonisairauksia varten
DE69305714D1 (de) Abspaltbare Carbonsäuren
FI940869A7 (fi) Menetelmä karboksyylihappoanhydridien valmistamiseksi
DE59205221D1 (de) 1-Alkoxyhexatrien-2-carbonsäureester
DE68910593D1 (de) Chinolinoncarbonsäuren.
FI934222A7 (fi) Pyridatsinonietikkahappoja
BR9610139A (pt) Derivado de ácido carboxílico
AU3076295A (en) Heterocyclyl-1-phenyl substituted quinolone carboxylic acids as antiviral agents